Gene Therapy For Hemophilia B

Brahm Goldstein, MD, Vice President, Research and Development, Hematology at CSL Behring, discusses HEMGENIX, a pivotal gene therapy for hemophilia B.     Hemophilia B is a bleeding disorder that slows the blood clotting process, caused by genetic changes in...